Application of 18F-FDG PET/MR in the diagnosis and treatment of non-small cell lung carcinoma / 中华核医学与分子影像杂志
Chinese Journal of Nuclear Medicine and Molecular Imaging
;
(6): 689-692, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-910819
ABSTRACT
18F-fluorodeoxyglucose(FDG) PET/MR has been more and more widely used in non-small cell lung cancer (NSCLC). Compared with PET/CT, PET/MR has more advantages, such as higher contrast resolution of soft tissues, less radiation dose and providing physicians with more functional parameters. This article summarizes the application status of 18F-FDG PET/MR in NSCLC in terms of diagnosis, staging, restaging, and prognosis.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
Idioma:
Chino
Revista:
Chinese Journal of Nuclear Medicine and Molecular Imaging
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS